Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10496964
rs10496964 		C 0.800 GeneticVariation GWASDB Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. 22949513

2012
dbSNP: rs10496964
rs10496964 		C 0.800 GeneticVariation GWASCAT Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. 22949513

2012
dbSNP: rs2717068
rs2717068 		T 0.800 GeneticVariation GWASDB Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. 22949513

2012
dbSNP: rs2717068
rs2717068 		T 0.800 GeneticVariation GWASCAT Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. 22949513

2012
dbSNP: rs111577701
rs111577701 		C 0.700 GeneticVariation GWASCAT Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. 25087078

2014
dbSNP: rs111908689
rs111908689 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs11663316
rs11663316 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs118166657
rs118166657 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs12204701
rs12204701 		A 0.700 GeneticVariation GWASCAT Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy. 30009487

2018
dbSNP: rs143543475
rs143543475 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs146173241
rs146173241 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs17084405
rs17084405 		A 0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs28498976
rs28498976 		A 0.700 GeneticVariation GWASCAT Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. 25087078

2014
dbSNP: rs2930491
rs2930491 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs4638568
rs4638568 		A 0.700 GeneticVariation GWASCAT Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. 30531953

2018
dbSNP: rs4895178
rs4895178 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs492146
rs492146 		A 0.700 GeneticVariation GWASCAT A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. 23962720

2014
dbSNP: rs535066
rs535066 		G 0.700 GeneticVariation GWASCAT Genetic determinants of common epilepsies: a meta-analysis of genome-wide association studies. 25087078

2014
dbSNP: rs61670327
rs61670327 		A 0.700 GeneticVariation GWASCAT A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. 23962720

2014
dbSNP: rs71547482
rs71547482 		0.700 GeneticVariation GWASCAT A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 30868120

2019
dbSNP: rs71568191
rs71568191 		A 0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs7328626
rs7328626 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs7461897
rs7461897 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs74912790
rs74912790 		A 0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015
dbSNP: rs9596837
rs9596837 		0.700 GeneticVariation GWASCAT GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. 26220383

2015